Log in
Enquire now
‌

US Patent 10111704 Intraosseous nerve treatment

Patent 10111704 was granted and assigned to Relievant Medsystems on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Relievant Medsystems
Relievant Medsystems
Date Filed
November 4, 2016
Date of Patent
October 30, 2018
Patent Applicant
Relievant Medsystems
Relievant Medsystems
Patent Application Number
15344284
Patent Citations Received
‌
US Patent 11890485 Implantable power adapter
0
‌
US Patent 11471210 Methods of denervating vertebral body using external energy source
‌
US Patent 11690667 Radiofrequency ablation of tissue within a vertebral body
0
‌
US Patent 11426199 Methods of treating a vertebral body
‌
US Patent 11471171 Bipolar radiofrequency ablation systems for treatment within bone
‌
US Patent 10265099 Systems for accessing nerves within bone
‌
US Patent 10357258 Systems and methods for creating curved paths through bone
‌
US Patent 10456187 Modulating nerves within bone using bone fasteners
‌
US Patent 10463423 Thermal denervation devices and methods
‌
US Patent 10478246 Ablation of tissue within vertebral body involving internal cooling
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10111704
Patent Primary Examiner
‌
Thomas Giuliani

Find more entities like US Patent 10111704 Intraosseous nerve treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.